Free Cash Flow: A measure of financial performance calculated as operating cash flow minus capital expenditures. Calculated as: Cash Flow from Operations + Net Property, Plant & Equipment Exp (a negative number)
Arbutus Biopharma Corporation (ABUS) had Free Cash Flow of $-39.27M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$14.08M |
|
$-33.50M |
|
-- |
|
$14.08M |
|
$52.24M |
|
$-38.16M |
|
$4.66M |
|
$-33.50M |
|
$-34.17M |
|
$-33.50M |
|
$-33.50M |
|
$-33.50M |
|
$-34.17M |
|
$-38.16M |
|
$-37.80M |
|
191.60M |
|
191.60M |
|
$-0.17 |
|
$-0.17 |
|
| Balance Sheet Financials | |
$94.46M |
|
$0.03M |
|
$0.16M |
|
$94.62M |
|
$6.01M |
|
-- |
|
$12.04M |
|
$18.04M |
|
$76.58M |
|
$76.58M |
|
$76.58M |
|
192.53M |
|
| Cash Flow Statement Financials | |
$-39.64M |
|
$15.58M |
|
$5.72M |
|
$36.33M |
|
$18.01M |
|
$-18.32M |
|
$6.95M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
15.73 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-270.96% |
|
-270.96% |
|
-268.39% |
|
-237.88% |
|
-237.88% |
|
|
Free Cash Flow |
$-39.27M |
-- |
|
-- |
|
-- |
|
0.15 |
|
-- |
|
9.73 |
|
37.50 |
|
-43.75% |
|
-43.75% |
|
-35.41% |
|
-43.75% |
|
$0.40 |
|
$-0.20 |
|
$-0.21 |
|